Articular cartilage degradation is prevented by tanshinone IIA through inhibiting apoptosis and the expression of inflammatory cytokines

Jia,Pei‑Tong; Zhang,Xing‑Lin; Zuo,Hai‑Ning; Lu,Xing; Li,Lin

doi:10.3892/mmr.2017.7340

Articular cartilage degradation is prevented by tanshinone IIA through inhibiting apoptosis and the expression of inflammatory cytokines

Authors:
- Pei‑Tong Jia
- Xing‑Lin Zhang
- Hai‑Ning Zuo
- Xing Lu
- Lin Li
View Affiliations

Affiliations: Department of Orthopedics, Yantaishan Hospital, Yantai, Shandong 264001, P.R. China, Department of Orthopedics, Shandong Jining No. 1 People's Hospital, Jining, Shandong 272011, P.R. China
Published online on: August 23, 2017 https://doi.org/10.3892/mmr.2017.7340
Pages: 6285-6289

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The present study aimed to investigate the effect of tanshinone IIA on the degradation of articular cartilage in a rat model of osteoarthritis (OA). The OA rat model was established by anterior cruciate ligament transection (ACLT) and medial meniscus resection (MMx). The animals were treated for 28 days with 0.25‑0.5 mg/kg doses of tanshinone IIA following ACLT + MMx. The knee joints of the rats in the ACLT + MMx group exhibited marked alterations in articular cartilage histopathology and higher Mankin scores, compared with those in the normal group. Tanshinone IIA treatment at a dose of 0.5 mg/kg significantly inhibited cartilage degradation and improved Mankin scores in the OA rat model (P<0.002). Tanshinone IIA treatment completely inhibited the ACLT + MMx‑induced accumulation of inflammatory cells and disintegration of synovial lining in the rats. An increase in the dose of tanshinone IIA between 0.25 and 0.5 mg/kg reduced the proportion of apoptotic chrondrocytes from 41 to 2% on day 29. Treatment of the rats in the ACLT + MMx group with 0.5 mg/kg doses of tanshinone IIA markedly inhibited the expression level of matrix metalloproteinase and increased the expression of tissue inhibitor of metalloproteinase in the rat articular cartilage tissues. Tanshinone IIA treatment significantly reduced the levels of inflammatory cytokines, including interleukin‑1β, tumor necrosis factor‑α and nitric oxide in rat serum samples. The protein expression levels of bone morphogenetic protein and transforming growth factor‑β were significantly increased by tanshinone IIA in the ACLT + MMx rats. Therefore, tanshinone IIA inhibited articular cartilage degradation through inhibition of apoptosis and expression levels of inflammatory cytokines, offering potential for use in the treatment of OA.

View Figures

View References

1	Gabriel SE, Crowson CS, Campion ME and O'Fallon WM: Direct medical costs unique to people with arthritis. J Rheumatol. 24:719–725. 1997.PubMed/NCBI
2	March LM and Bachmeier CJ: Economics of osteoarthritis: A global perspective. Baillieres Clin Rheumatol. 11:817–834. 1997. View Article : Google Scholar : PubMed/NCBI
3	Martel-Pelletier J, Lajeunesse D and Pelletier JP: Etiopathogenesis of osteoarthritisArthritis and Allied conditions: A Textbook of Rheumatology. Koopman WJ and Moreland LW: 2. 15th. Lippincott Williams & Wilkins; Philadelphia: pp. 2199–2226. 2005
4	Buckwalter JA and Mankin HJ: Articular cartilage: Degeneration and osteoarthritis, repair, regeneration and transplantation. Instr Course Lect. 47:487–504. 1998.PubMed/NCBI
5	Aigner T and Kim HA: Apoptosis and cellular vitality: Issues in osteoarthritic cartilage degeneration. Arthritis Rheum. 46:1986–1996. 2002. View Article : Google Scholar : PubMed/NCBI
6	Kapoor M, Martel-Pelletier J, Lajeunesse D, Pelletier JP and Fahmi H: Role of proinflammatory cytokines in the pathophysiology of osteoarthritis. Nat Rev Rheumatol. 7:33–42. 2011. View Article : Google Scholar : PubMed/NCBI
7	Aizawa T, Kon T, Einhorn TA and Gerstenfeld LC: Induction of apoptosis in chondrocytes by tumor necrosis factor-alpha. J Orthop Res. 19:785–796. 2001. View Article : Google Scholar : PubMed/NCBI
8	Fernandes JC, Martel-Pelletier J and Pelletier JP: The role of cytokines in osteoarthritis pathophysiology. Biorheology. 39:237–246. 2002.PubMed/NCBI
9	Attur M, Al-Mussawir HE, Patel J, Kitay A, Dave M, Palmer G, Pillinger MH and Abramson SB: Prostaglandin E2 exerts catabolic effects in osteoarthritis cartilage: Evidence for signaling via the EP4 receptor. J Immunol. 181:5082–5088. 2008. View Article : Google Scholar : PubMed/NCBI
10	Abramson SB: Osteoarthritis and nitric oxide. Osteoarthritis Cartilage. 16 Suppl 2:S15–S20. 2008. View Article : Google Scholar : PubMed/NCBI
11	Burger D, Rezzonico R, Li JM, Modoux C, Pierce RA, Welgus HG and Dayer JM: Imbalance between interstitial collagenase and tissue inhibitor of metalloproteinases 1 in synoviocytes and fibroblasts upon direct contact with stimulated T lymphocytes: Involvement of membrane-associated cytokines. Arthritis Rheum. 41:1748–1759. 1998. View Article : Google Scholar : PubMed/NCBI
12	Harris RE, Namboodiri KK and Farrar WB: Nonsteroidal antiinflammatory drugs and breast cancer. Epidemiology. 7:203–205. 1996. View Article : Google Scholar : PubMed/NCBI
13	Baron JA and Sandler RS: Nonsteroidal anti-inflammatory drugs and cancer prevention. Annu Rev Med. 51:511–523. 2000. View Article : Google Scholar : PubMed/NCBI
14	Cohen I, Tagliaferri M and Tripathy D: Traditional Chinese medicine in the treatment of breast cancer. Semin Oncol. 29:563–574. 2002. View Article : Google Scholar : PubMed/NCBI
15	Kumar NB, Allen K and Bell H: Perioperative herbal supplement use in cancer patients: Potential implications and recommendations for presurgical screening. Cancer Control. 12:149–157. 2005. View Article : Google Scholar : PubMed/NCBI
16	Lee DS, Lee SH, Noh JG and Hong SD: Antibacterial activities of cryptotanshinone and dihydrotanshinone I from a medicinal herb, Salvia miltiorrhiza Bunge. Biosci Biotechnol Biochem. 63:2236–2239. 1999. View Article : Google Scholar : PubMed/NCBI
17	Cao EH, Liu XQ, Wang JJ and Xu NF: Effect of natural antioxidant tanshinone II-A on DNA damage by lipid peroxidation in liver cells. Free Radic Biol Med. 20:801–806. 1996. View Article : Google Scholar : PubMed/NCBI
18	Kang BY, Chung SW, Kim SH, Ryu SY and Kim TS: Inhibition of interleukin-12 and interferon-gamma production in immune cells by tanshinones from Salvia miltiorrhiza. Immunopharmacology. 49:355–361. 2000. View Article : Google Scholar : PubMed/NCBI
19	Kim SY, Moon TC, Chang HW, Son KH, Kang SS and Kim HP: Effects of tanshinone I isolated from Salvia miltiorrhiza Bunge on arachidonic acid metabolism and in vivo inflammatory responses. Phytother Res. 16:616–620. 2002. View Article : Google Scholar : PubMed/NCBI
20	Sung HJ, Choi SM, Yoon Y and An KS: Tanshinone IIA, an ingredient of Salvia miltiorrhiza Bunge, induces apoptosis in human leukemia cell lines through the activation of caspase-3. Exp Mol Med. 31:174–178. 1999. View Article : Google Scholar : PubMed/NCBI
21	Wu WL, Chang WL and Chen CF: Cytotoxic activities of tanshinones against human carcinoma cell lines. Am J Chin Med. 19:207–216. 1991. View Article : Google Scholar : PubMed/NCBI
22	Wang N, Luo HW, Niwa M and Ji J: A new platelet aggregation inhibitor from Salvia miltiorrhiza. Planta Med. 55:390–391. 1989. View Article : Google Scholar : PubMed/NCBI
23	Xu Y, Dai GJ, Liu Q, Liu ZL, Song ZQ, Li L, Chen WH and Lin N: Sanmiao formula inhibits chondrocyte apoptosis and cartilage matrix degradation in a rat model of osteoarthritis. Exp Ther Med. 8:1065–1074. 2014. View Article : Google Scholar : PubMed/NCBI
24	Mankin HJ, Dorfman H, Lippiello L and Zarins A: Biochemical and metabolic abnormalities in articular cartilage from osteo-arthritic human hips. II Correlation of morphology with biochemical and metabolic data. J Bone Joint Surg Am. 53:523–537. 1971. View Article : Google Scholar : PubMed/NCBI
25	Jubb RW and Fell HB: The breakdown of collagen by chondrocytes. J Pathol. 130:159–167. 1980. View Article : Google Scholar : PubMed/NCBI
26	Naito K, Watari T, Muta T, Furuhata A, Iwase H, Igarashi M, Kurosawa H, Nagaoka I and Kaneko K: Low-intensity pulsed ultrasound (LIPUS) increases the articular cartilage type II collagen in a rat osteoarthritis model. J Orthop Res. 28:361–369. 2010.PubMed/NCBI
27	Goldring MB, Otero M, Plumb DA, Dragomir C, Favero M, El Hachem K, Hashimoto K, Roach HI, Olivotto E, Borzì RM and Marcu KB: Roles of inflammatory and anabolic cytokines in cartilage metabolism: signals and multiple effectors converge upon MMP-13 regulation in osteoarthritis. Eur Cell Mater. 21:202–220. 2011. View Article : Google Scholar : PubMed/NCBI
28	Wetzel M, Li L, Harms KM, Roitbak T, Ventura PB, Rosenberg GA, Khokha R and Cunningham LA: Tissue inhibitor of metalloproteinases-3 facilitates Fas-mediated neuronal cell death following mild ischemia. Cell Death Differ. 15:143–151. 2008. View Article : Google Scholar : PubMed/NCBI
29	Hashimoto S, Nishiyama T, Hayashi S, Fujishiro T, Takebe K, Kanzaki N, Kuroda R and Kurosaka M: Role of p53 in human chondrocyte apoptosis in response to shear strain. Arthritis Rheum. 60:2340–2349. 2009. View Article : Google Scholar : PubMed/NCBI
30	Del Carlo M Jr and Loeser RF: Nitric oxide-mediated chondrocyte cell death requires the generation of additional reactive oxygen species. Arthritis Rheum. 46:394–403. 2002. View Article : Google Scholar : PubMed/NCBI
31	Shuler FD, Georgescu HI, Niyibizi C, Studer RK, Mi Z, Johnstone B, Robbins RD and Evans CH: Increased matrix synthesis following adenoviral transfer of a transforming growth factor beta1 gene into articular chondrocytes. J Orthop Res. 18:585–592. 2000. View Article : Google Scholar : PubMed/NCBI